Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2
Hadjer Khelfaoui, Dalal Harkati, Basil A. Saleh
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 18, pp. 7246-7262
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Yan Ling Ng, Cyrill Kafi Salim, Justin Jang Hann Chu
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107930-107930
Open Access | Times Cited: 132
Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
Chinmayee Choudhury, N. Arul Murugan, U. Deva Priyakumar
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1847-1861
Open Access | Times Cited: 79
Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 Mpro
Olivier Sheik Amamuddy, Gennady M. Verkhivker, Özlem Taştan Bishop
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 10, pp. 5080-5102
Open Access | Times Cited: 84
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Modelling the DFT structural and reactivity study of feverfew and evaluation of its potential antiviral activity against COVID-19 using molecular docking and MD simulations
Shradha Lakhera, Kamal Devlal, Arabinda Ghosh, et al.
Chemical Papers (2022) Vol. 76, Iss. 5, pp. 2759-2776
Open Access | Times Cited: 46
New approach methods to assess developmental and adult neurotoxicity for regulatory use: a PARC work package 5 project
Tamara Tal, Oddvar Myhre, Ellen Fritsche, et al.
Frontiers in Toxicology (2024) Vol. 6
Open Access | Times Cited: 14
A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
Saeid Maghsoudi, Bahareh Taghavi Shahraki, Fatemeh Rameh, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 699-721
Open Access | Times Cited: 35
Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking
José Luis Vique‐Sánchez
Bioorganic & Medicinal Chemistry (2021) Vol. 33, pp. 116040-116040
Open Access | Times Cited: 36
Potency of Xanthone Derivatives from Garcinia mangostana L. for COVID-19 Treatment through Angiotensin-Converting Enzyme 2 and Main Protease Blockade: A Computational Study
Cecep Suhandi, Siti Sarah Alfathonah, Aliya Nur Hasanah
Molecules (2023) Vol. 28, Iss. 13, pp. 5187-5187
Open Access | Times Cited: 13
WGS-based screening of the co-chaperone protein DjlA-induced curved DNA binding protein A (CbpA) from a new multidrug-resistant zoonotic mastitis-causing Klebsiella pneumoniae strain: a novel molecular target of selective flavonoids
Mohammad Habibur Rahman, Salauddin Al Azad, Mohammad Fahim Uddin, et al.
Molecular Diversity (2023)
Closed Access | Times Cited: 12
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
Sajjan Rajpoot, Tomokazu Ohishi, Ashutosh Kumar, et al.
Drugs in R&D (2021) Vol. 21, Iss. 3, pp. 273-283
Open Access | Times Cited: 26
Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury
Tanzina Sharmin Nipun, Tanzila Ismail Ema, Md. Abdur Rashid Mia, et al.
Journal of Advanced Veterinary and Animal Research (2021) Vol. 8, Iss. 4, pp. 1-1
Open Access | Times Cited: 25
SARS-CoV-2: Origin, Evolution, and Targeting Inhibition
Shuo Ning, Beiming Yu, Yanfeng Wang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 24
Identification of Potential Antiviral Inhibitors from Hydroxychloroquine and 1,2,4,5-Tetraoxanes Analogues and Investigation of the Mechanism of Action in SARS-CoV-2
Ryan da Silva Ramos, Rosivaldo S. Borges, João Sammy Nery de Souza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1781-1781
Open Access | Times Cited: 18
In silico screening of a series of 1,6-disubstituted 1 H -pyrazolo[3,4- d ]pyrimidines as potential selective inhibitors of the Janus kinase 3
Abdelmoujoud Faris, Hanine Hadni, Basil A. Saleh, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 9, pp. 4456-4474
Closed Access | Times Cited: 10
Effectiveness of estrogen and its derivatives over dexamethasone in the treatment of COVID-19
Darakhshan Parveen, Anwesha Das, Shaista Amin, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1858-1874
Closed Access | Times Cited: 9
Green synthesis of Co-Zn-Ni trimetallic oxide nanoparticles using Cicer Arietinum leaf extract and their antibiofilm activity: Experimental and computational study
Nidhal M. Sher Mohammed, Shinwar A. Idrees
Materials Science and Engineering B (2024) Vol. 310, pp. 117681-117681
Closed Access | Times Cited: 3
Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein
Loai M. Saadah, Ghina’a Abu Deiab, Qosay Al‐Balas, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5605-5605
Open Access | Times Cited: 21
A Multidisciplinary Approach to Coronavirus Disease (COVID-19)
Aliye Gediz Ertürk, Arzu Şahin, Ebru Batı Ay, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3526-3526
Open Access | Times Cited: 20
A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma
Shahrukh Qureshi, Ravina Khandelwal, Maddala Madhavi, et al.
Current Topics in Medicinal Chemistry (2021) Vol. 21, Iss. 9, pp. 790-818
Closed Access | Times Cited: 16
Shedding light into the biological activity of aminopterin,viamolecular structural, docking, and molecular dynamics analyses
Sefa Çeli̇k, Gözde Yılmaz, Sevim Akyüz, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7773-7794
Closed Access | Times Cited: 6
SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids
Gideon Ampoma Gyebi, Oludare M. Ogunyemi, Ibrahim M. Ibrahim, et al.
Journal of Genetic Engineering and Biotechnology (2021) Vol. 19, Iss. 1, pp. 113-113
Open Access | Times Cited: 15
Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19
Sepehr Shafiee, Luca Cegolon, Mostafa Khafaei, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease
Wei Wei, Ni Kong, Mengzhen Liu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 616, pp. 8-13
Open Access | Times Cited: 9
Biomolecular interactions with nanoparticles: applications for coronavirus disease 2019
Mohammed A. H. Farouq, Mohammed M. Al Qaraghuli, Karina Kubiak-Ossowska, et al.
Current Opinion in Colloid & Interface Science (2021) Vol. 54, pp. 101461-101461
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top